Get started
Author

Atsumi Taguchi

Observed name: Taguchi, Atsumi
ORCID: 0000-0002-6231-6727
Observed ORCID: 0000-0002-6231-6727
OpenAlex ID: A5088237353
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
2018 · Hiroki Maruyama, Kaori Miyata, et al. · Genetics in Medicine · 98
PDF
A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis
2013 · Atsumi Taguchi, Hiroki Maruyama, et al. · Biochemical Journal · 65
Preclinical Efficacy and Safety of 1-Deoxygalactonojirimycin in Mice for Fabry Disease
2008 · Satoshi Ishii, Hui-Hwa Chang, et al. · Journal of Pharmacology and Experimental Therapeutics · 39
Medullary thick ascending limb impairment in the Gla tm Tg(CAG‐A4GALT ) Fabry model mice
2018 · Hiroki Maruyama, Atsumi Taguchi, et al. · The FASEB Journal · 24
PDF
Low bone mineral density due to secondary hyperparathyroidism in the Gla tm Tg(CAG‐A4GALT) mouse model of Fabry disease
2020 · Hiroki Maruyama, Atsumi Taguchi, et al. · FASEB BioAdvances · 13
PDF
Determination of globotriaosylceramide analogs in the organs of a mouse model of Fabry disease
2020 · Satoshi Ishii, Atsumi Taguchi, et al. · Journal of Biological Chemistry · 13
Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease
2023 · Atsumi Taguchi, Satoshi Ishii, et al. · Molecular Genetics and Metabolism Reports · 11
Plasma Globotriaosylsphingosine and ?-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort
2021 · Hiroki Maruyama, Atsumi Taguchi, et al. · Current Issues in Molecular Biology · 8
PDF
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
2018 · Hiroki Maruyama, Kaori Miyata, et al. · Genetics in Medicine · 6
PDF
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
2018 · Hiroki Maruyama, Kaori Miyata, et al. · Genetics in Medicine · 5
PDF
Synthesis of 8-epi-l-swainsonine, related C6 alkylated derivatives and their α-l-rhamnosidase inhibition
2024 · Yuna Shimadate, Saki Oshima, et al. · Tetrahedron Letters · 4
Borylated 5-Membered Ring Iminosugars: Synthesis and Biological Evaluation for Glycosidase Inhibition and Anticancer Properties for Application in Boron Neutron Capture Therapy (BNCT)—Part 2
2025 · Kate Prichard, Kosuke Yoshimura, et al. · Pharmaceuticals · 3
PDF
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
2019 · Hiroki Maruyama, Kaori Miyata, et al. · Genetics in Medicine · 1
PDF
Synthesis of Polyhydroxylated Dihydro-Oxazines, Their Reactivity Studies, and Applications in the Construction of 1,2-Oxazinane Iminosugar Library with Bioactivities
2026 · Chen-Hao Xu, Kosuke Yoshimura, et al. · The Journal of Organic Chemistry
4-Dehydroxymethyl-4- C -biphenyl-DAB derivatives: introduction of a biphenyl group at the C4 position shifts the binding selectivity, resulting in improved affinity for lysosomal acid β-glucocerebrosidase
2026 · Kosuke Yoshimura, Izumi Nakagome, et al. · Organic & Biomolecular Chemistry
Correction: 4-Dehydroxymethyl-4- C -biphenyl-DAB derivatives: introduction of a biphenyl group at the C4 position shifts the binding selectivity, resulting in improved affinity for lysosomal acid β-glucocerebrosidase
2026 · Kosuke Yoshimura, Izumi Nakagome, et al. · Organic & Biomolecular Chemistry
PDF
グロボトリアオシルセラミド合成を活発化させることにより作製したファブリー病 病態モデルマウス
2015 · Taguchi, Atsumi · Institutional Repositories DataBase (IRDB)
Works count: 17
Citation count: 290
H-index: 8
I10-index: 7
Year
Topic
Type